Canada markets closed

VTGN Jan 2025 5.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.8100+0.0300 (+3.85%)
At close: 03:50PM EDT
Full screen
Previous Close0.7800
Open0.8100
Bid0.5000
Ask1.7000
Strike5.00
Expire Date2025-01-17
Day's Range0.8100 - 0.8100
Contract RangeN/A
Volume12
Open Interest126
  • Insider Monkey

    VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2024 Earnings Call Transcript

    VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2024 Earnings Call Transcript June 11, 2024 Operator: Greetings, and welcome to the Vistagen Therapeutics Fiscal Year-End 2024 Corporate Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. […]

  • Business Wire

    Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

    SOUTH SAN FRANCISCO, Calif., June 11, 2024--Vistagen (Nasdaq: VTGN), a neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, today reported financial results for its fiscal year ended March 31, 2024, and provided a corporate update.

  • Business Wire

    Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024

    SOUTH SAN FRANCISCO, Calif., June 07, 2024--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced it will host a conference call and webcast on Tuesday, June 11, 2024, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2024 ended March 31, 2024 and provide a corporate update.